tiprankstipranks
Trending News
More News >
Immucell Corp. (ICCC)
NASDAQ:ICCC
US Market

Immucell (ICCC) Financial Statements

Compare
78 Followers

Immucell Financial Overview

Immucell's market cap is currently $54.91M. The company's EPS TTM is $-0.315; its P/E ratio is -53.37; Immucell is scheduled to report earnings on March 4, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 27.64M$ 26.49M$ 17.47M$ 18.57M$ 19.24M
Gross Profit$ 11.45M$ 7.94M$ 4.40M$ 7.65M$ 8.66M
Operating Income$ 1.65M$ -1.64M$ -5.75M$ -2.30M$ 257.38K
EBITDA$ 4.43M$ 1.07M$ -2.50M$ 349.99K$ 2.70M
Net Income$ -1.04M$ -2.16M$ -5.77M$ -2.49M$ -78.29K
Balance Sheet
Cash & Short-Term Investments$ 3.81M$ 3.76M$ 978.74K$ 5.79M$ 10.19M
Total Assets$ 42.53M$ 45.10M$ 43.81M$ 44.86M$ 44.47M
Total Debt$ 0.00$ 15.10M$ 16.69M$ 12.48M$ 10.27M
Net Debt$ -3.81M$ 11.34M$ 15.71M$ 6.69M$ 89.03K
Total Liabilities$ 0.00$ 17.58M$ 18.82M$ 14.48M$ 11.89M
Stockholders' Equity$ 0.00$ 27.52M$ 24.99M$ 30.38M$ 32.58M
Cash Flow
Free Cash Flow$ 0.00$ -107.82K$ -6.57M$ -5.52M$ -1.65M
Operating Cash Flow$ 0.00$ 357.90K$ -4.67M$ -1.54M$ 954.17K
Investing Cash Flow$ -1.21M$ -461.23K$ -1.89M$ -3.96M$ -1.60M
Financing Cash Flow$ -1.21M$ 2.88M$ 1.75M$ 1.11M$ 3.88M
Currency in USD

Immucell Earnings and Revenue History

Immucell Debt to Assets

Immucell Cash Flow

Immucell Forecast EPS vs Actual EPS